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OBJECTIVES This study was designed to determine the feasibility and accuracy of intracardiac echocardi-
ography (ICE) in guiding percutaneous closure of atrial septal defects (ASD).
BACKGROUND Intracardiac echocardiography is a novel imaging technique that might be used to guide
interventional procedures. The sensitivity and specificity of ICE, compared to standard
imaging techniques, in detecting potentially adverse procedural events and guiding remedial
action will be an important consideration in its use.
METHODS In a prospective study, 24 patients underwent device closure of ASD using ICE as the primary
echocardiographic imaging modality. Feasibility was expressed as proportion of cases in which
complete diagnostic ICE imaging was achieved. Accuracy was expressed as the percent
agreement between ICE and simultaneously performed transesophageal echocardiography
(TEE).
RESULTS High-quality ICE images were acquired in all patients, though images were limited in two
patients with aneurysmal septa. Intracardiac echocardiography successfully guided closure of
24 out of 25 ASDs (96%) in 23 patients. There was close agreement between ICE and TEE
in their assessment of device position and the adequacy of septal capture before device release
(98%) and in identifying the presence of significant residual shunts. Intracardiac echocardi-
ography detected all potentially adverse events, including four malpositions, and guided
appropriate remedial action.
CONCLUSIONS Intracardiac echocardiography guided device closure of secundum ASDs is feasible in the
majority of patients and provides diagnostic data comparable to TEE. These data indicate
that ICE may be used to guide routine closure of ASDs in adults without the need for TEE
and general anesthesia. (J Am Coll Cardiol 2003;41:285–92) © 2003 by the American
College of Cardiology Foundation
Transcatheter closure of atrial septal defects (ASD) has been
established as a safe and effective treatment modality, with
excellent short- and medium-term results (1–3). During the
procedure transesophageal echocardiography (TEE) is used
to assess the defect with reference to size and position,
adequacy of the septal rim, and proximity to surrounding
structures, and to ensure satisfactory deployment of the
device before its release from the delivery system. Because of
the discomfort associated with TEE and the need for
adequate airway protection in the supine patient, the pro-
cedure is usually performed under general anesthesia with
endotracheal intubation, which adds additional time, com-
plexity, and cost to the procedure.
The recent development of intracardiac echocardiography
(ICE) has added a further dimension to the imaging
modalities available to cardiologists (4). With the transducer
positioned in the right heart, ICE accurately delineates
cardiac anatomy and has been used to guide transseptal
needle punctures (5). Advantages of currently available ICE
transducers include high-quality near-field imaging, the
ability to achieve multiple image planes using a steerable
quadridirectional catheter, and full-color flow and Doppler
capabilities. Early reports in a small number of patients have
suggested that ICE may be useful in guiding the percuta-
neous closure of ASDs, avoiding the need for TEE and
general anesthesia (6). However, no systematic assessment
of the utility of ICE in this capacity has been reported. We
therefore prospectively assessed the feasibility and accuracy
of ICE in guiding the percutaneous closure of secundum
ASD and assessing the success of device deployment.
METHODS
Consecutive patients referred to the University of Toronto
Congenital Cardiac Centre for Adults for device closure of
a secundum ASD were eligible for the study. Before the
procedure all patients had undergone a TEE examination to
determine the number, position, and size of the defect(s).
Patients with a secundum ASD (diameter 40 mm) with
an adequate circumferential rim were considered suitable for
device closure. Defects were classified on the basis of their
size and their proximity to the aorta (central defects aortic rim
5 mm, anterosuperior defects aortic rim 5 mm). The
septum was deemed to be aneurysmal if the total excursion
throughout the cardiac cycle was 15 mm. The study was
approved by the University Health Network research ethics
committee and all patients gave informed written consent.
Study protocol. The procedure was performed under gen-
eral anesthesia, with the image intensifier positioned with a
30° left anterior oblique and 30° cranial tilt throughout the
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procedure. All patients were administered heparin 3,000
IU/kg and antibiotic prophylaxis (1 g Cephalexin) during
the procedure. Intracardiac echocardiography was used as
the primary echocardiographic imaging modality to assess
the anatomy of the intraatrial septum and surrounding
structures before attempted closure of the defect, to guide
deployment of the occluding device, and to assess its
position after release. The feasibility and accuracy of ICE in
assessing the salient features of the procedure and determin-
ing a successful outcome were assessed by sequential inde-
pendent TEE examinations performed during the proce-
dure. Both the ICE and TEE operators were blind to the
findings of the other modality.
ICE. An 11-F valved sheath was inserted percutaneously
into the right femoral vein and a 3.3 mm (10F) diameter
Acunav ICE transducer interfaced with a Sequoia ultra-
sound system (both Acuson, Mountainview, California) was
advanced into the right atrium (RA). The catheter has a
quadridirectional steerable tip that houses a side-firing,
multiple-frequency (5 to 10 MHz) phased-array transducer,
with two-dimensional and color Doppler imaging modes.
The scan plane is along the axis of the catheter with a range
of tissue penetration from 2 to 120 mm. Intracardiac echo
images, similar to those derived from TEE, were obtained
in the following sequence. On entering the RA the trans-
ducer was rotated anteriorly to obtain an image of the
tricuspid valve (TV) and right ventricular (RV) inlet (Fig.
1A). The transducer tip was then flexed posteriorly and
rotated clockwise to view the aorta and atrial septum in the
long axis (Fig. 1B). Movement of the catheter cranially and
caudally afforded excellent views of the superior and inferior
aspects of the atrial septum (Fig. 1C). The course of the
right-sided pulmonary veins could be easily imaged from the
junction of the RA and superior vena cava by rotating the
catheter clockwise. A short-axis image of the aortic valve and
atrial septum was achieved by further posterior flexion and
clockwise rotation of the transducer, such that the catheter tip
was directed toward the TV (Fig. 1D).
TEE. Transesophageal echocardiography was performed
using a multiplane TEE probe (3.5 to 5 MHz) and a
Hewlett-Packard Sonos 2500 ultrasound system. Standard
transverse (0° to 60°) and longitudinal (90° to 20°) views
were acquired as previously described (7).
ASD closure protocol. Defects were closed percutaneously
using an Amplatzer Septal Occluder (AGA Medical,
Golden Valley, Minnesota) or Cardioseal device (NMT
Medical, Boston, Massachusetts), using techniques previ-
ously described (1,8).
After the initial assessment of ASD anatomy, confirming
its suitability for device closure, the stretched diameter of
the defect was determined by fluoroscopy, using a 34-mm
diameter contrast-filled sizing balloon (AGA Medical)
inflated across the defect until a clear waist was visible. A
long sheath was advanced over the guide wire to the left
upper pulmonary vein and the distal disk of an occluding
device of the appropriate size was deployed in the left atrium
by withdrawal of the sheath. With a combination of ICE
and fluoroscopy to guide the operator, the device was
withdrawn until it abutted the atrial septum, and the right
atrial disk was deployed by further withdrawal of the sheath.
Once deployed, but before release, the device position was
again assessed by ICE imaging (Fig. 2). Long- and short-
axis views were used to assess adequacy of capture of the
aortic, posterior, and caval rims of the defect. Color flow
Doppler mapping was used to assess the presence of residual
leaks and additional unrecognized defects. Devices that
were deemed to be malpositioned were withdrawn within
the sheath and redeployed. Once the operators were satis-
fied with device position, a further confirmatory TEE
examination was performed. The interventional cardiologist
remained blind to the results and images of the TEE study,
other than receiving a verbal confirmation of the satisfactory
position of the device before its release after corresponding
ICE and TEE data were collected. After confirmation of a
satisfactory device position, the device was released and
further independent ICE and TEE examinations were
performed. All adverse events that might affect the success of
the interventional procedure were logged. In the event that the
TEE indicated an unsatisfactory device position, a further
assessment of the device position was made using ICE to
ascertain the source of the conflicting results. A further attempt
was made to redeploy the device if deemed appropriate using
ICE, fluoroscopy, and TEE in an open fashion.
Patients were discharged taking aspirin 325 mg once per
day to protect against thrombosis formation on the device.
All patients were reviewed at six to eight weeks after device
implantation with a clinical examination, transthoracic
echocardiogram, and 12-lead ECG.
Data analysis. Identical analysis protocols were used for
the TEE and ICE images. For each device the position was
assessed in orthogonal transverse and longitudinal planes
similar to the standard transverse (0 to 60°) and longitudinal
(90° to 120°) TEE views. Satisfactory septal capture was
assessed for both rims in each view using a combination of
two-dimensional echocardiography and color flow Doppler.
Before release of the device, septal capture was classified as
satisfactory (septum visible between the right and left atrial
discs and absence of color flow lateral to device margin) or
unsatisfactory (device malposition with no obvious septum
between discs or presence of residual leak with a color flow
signal seen lateral to device in both the atria). A dichoto-
mous variable was chosen, as this best represents the
Abbreviations and Acronyms
ASD  atrial septal defect
ICE  intracardiac echocardiography
RA  right atrium
RV  right ventricle
TEE  transoesophageal echocardiography
TV  tricuspid valve
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Figure 1. Fluoroscopic position of the intracardiac transducer with corresponding echocardiographic images. (A) Long-axis view of the tricuspid valve (TV),
right ventricle (RV), and right ventricular outflow tract viewed from the right atrium (RA). (B) Rotation of the catheter clockwise reveals a long-axis view
of atrial septum and the left atrium (LA); color Doppler demonstrates an atrial septal defect. (C) Advancing the transducer cranially with slight posterior
flexion reveals the sinus venosus septum, superior vena cava (SVC), and origin of the right upper pulmonary vein (RUPV). (D) Further posterior flexion
and rotation of the transducer towards the TV provides a short-axis image of the aorta (Ao), atrial septum, and atrial septal defect.
decision-making process taken by the operator, in which
information from a number of sources was integrated
(position of the device, presence of visible septum between
the discs, presence of color flow through or round the
device) before a decision on device release or redeployment.
After device release a similar detailed assessment was per-
formed in two orthogonal planes using each modality, and
assessed as no leak, residual leak (trivial, 4 mm; moderate,
4 mm), or device malposition (failure of septal capture).
The primary end point for this study was the agreement
of ICE and TEE imaging in assessing the position of the
occluding device before release, expressed as the percent
agreement. Secondary end points were the agreement be-
tween ICE and TEE in the predeployment assessment of
ASD anatomy with respect to the number of defects, their
position and size, the adequacy of septal rims, postrelease
assessment of device position, and the presence of residual
leaks. Feasibility of ICE-guided device closure of ASDs was
expressed as the proportion of cases in which complete
diagnostic ICE imaging was achieved.
RESULTS
Twenty-four patients were entered in the study (6 men, 17
women, median age 43 [18 to 74] years). Individual patient
demographics and characteristics of their ASD are given in
Table 1. In one patient with significant right heart dilation
but a poor-quality preprocedural TEE performed in an
outlying hospital, only a small patent foramen ovale was
found. Further assessment by ICE demonstrated anomalous
drainage of the right-sided pulmonary veins to the RA. This
finding was confirmed by angiography and TEE, and the
patient was referred for surgery. In the remaining 23
patients, five (20%) had multiple defects, though in only two
were the additional defects of sufficient size to warrant
closure. Six patients (26%) had an aneurysmal intraatrial
septum. Of the 25 ASDs considered for closure, the median
(range) ASD size was 14 mm (range 4 to 24 mm); stretched
diameter 22 mm (range 6 to 29 mm). Eleven ASDs (44%)
were anterosuperior with a deficient aortic rim.
Twenty-four ASDs were closed using the Amplatzer
Septal Occluder (median size 24 mm; range 6 to 26 mm). In
one patient with a grossly aneurysmal septum and two small
ASDs, a 40-mm Cardioseal device was deployed covering
both defects. The median (range) procedure time, fluoros-
copy time, and radiation dose were 79 (31 to 140) min, 9 (2
to 50) min and 2,768 (648-13,060) cGy/cm2, respectively.
Feasibility. High-quality ICE images of the atrial septum
were achieved, with multiple views in transverse and longi-
Figure 2. (A) Amplatzer septal occluder with both left atrial (LA) and right atrial (RA) discs visible during deployment. (B) Short-axis view of Amplatzer
device following deployment. (C and D) Long-axis views illustrating capture of the membranous inferior and muscular superior septum.
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tudinal planes, defining the anatomy of the posterior wall,
the sinus venosus septum, and pulmonary venous drainage
in all the patients (Table 2). Intracardiac echocardiography
was used as the primary imaging modality to close 24 of the
25 (96%) ASDs where closure was attempted. In two
patients with grossly aneurysmal atrial septa, there was some
limitation in imaging the complete septum owing to its
prolapse into the RA. In one case, early in the series (Patient
6), this necessitated use of TEE to monitor the device
closure of a second defect, which was not well visualized
with ICE. In a second patient (Patient 12), a second small
defect identified by TEE was not seen with ICE. Despite
this ICE was used to guide closure of a larger defect using
a 40 mm Cardioseal device covering both defects and
reducing aneurysmal movement of the atrial septum.
Concordance of ICE and TEE. There was a close agree-
ment between ICE and TEE in the assessment of the
number of defects in each patient (86%) and their position
with respect to the aorta and vena cavae. The mean
difference in the maximum diameter measured by ICE and
TEE was 0.14 mm (range 7 to 6 mm).
There was close agreement (98%) between ICE and TEE
in the assessment of device position and adequacy of septal
capture before its release from the delivery system. In only
two patients did the TEE assessment contradict that of
ICE. In one patient, following a satisfactory assessment of
device position by ICE, the device became dislodged while
still attached to the delivery system during patient move-
ment induced by lightening of the general anesthetic.
Malposition of the device was noted during the subsequent
TEE assessment, with both discs on the right atrial aspect
of the aortic rim and the presence of a large paradevice
residual leak. On subsequent reassessment with ICE this
malposition was easily demonstrated and noted to be
different from the original position. The device was rede-
ployed using ICE, and the subsequent TEE confirmed a
satisfactory position. In a separate patient with a superior







ICE TEE Stretched Size (mm) Type
1 M 64 N 1 AS 19 24 23 26 ASO
2 F 74 N 1 C 7 14 18 20 ASO
3 F 30 Y 1 AS 21 21 22 26 ASO
4 M 62 N 3 C 22 20 20 22 ASO
AS 13 14 16 18 ASO
5 M 67 N 1 C 14 14 14 16 ASO
6 F 55 Y 3 C 4 4 6 6 ASO
C 12 16 20 20 ASO
7 M 41 Y 1 C 21 20 25 28 ASO
8 F 43 N 2 AS 13 17 21 24 ASO
9 F 37 N 1 C 23 23 22 24 ASO
10 F 66 N 1 C 17 16 21 24 ASO
11 F 18 N 1 AS 19 19 23 28 ASO
12 F 56 Y 2 C 11 12 12 40 CS
13 F 60 Y 1 C 11 13 16 18 ASO
14 F 42 N 1 AS 17 16 20 22 ASO
15 M 45 N 1 C 12 10 12 15 ASO
16 M 24 N 2 AS 21 19 22 24 ASO
17 F 25 N 1 C 21 16 24 26 ASO
18 F 25 Y N 0 N/A
19 F 22 N 1 AS 14 20 26 28 ASO
20 F 47 N 1 AS 10 18 29 30 ASO
21 F 38 N 1 AS 23 20 24 26 ASO
22 F 34 N 1 AS 16 16 22 24 ASO
23 F 25 Y 1 C 9 12 23 24 ASO
24 F 69 N 1 C 10 9 22 24 ASO
AIAS  aneurysmal intra-atrial septum; APFO  Amplatzer Patent Foramen Ovale occluder; AS  anterosuperior position; ASD  atrial septal defect; ASO  Amplatzer
Septal Occluder; C  central position; CS  Cardioseal device; ICE  intracardiac echocardiography; N  no; TEE  transesophageal echocardiography; Y  Yes.
Table 2. Feasibility of Intracardiac Echocardiographic Guided
Device Closure of Atrial Septal Defects
N/Denominator % Feasibility
Uncomplicated vascular access 37/37 100
Complete imaging of IAS* 35/37 95
Complete imaging of sinus
venosus septum
37/37 100
Complete imaging of pulmonary
veins
37/37 100
Guidance of device closure of
ASD
38/39 97
Complete imaging of device
in situ†
39/39 100
Overall feasibility 35/36 97
*In two patients with grossly aneurysmal IAS complete imaging was not possible with
ICE. †Although not used to guide closure of one ASD, ICE was able to adequately
assess the device once in situ.
ASD  atrial septal defect; IAS  intraatrial septum; ICE  intracardiac
echocardiography.
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ASD, the initial position of the device following deploy-
ment appeared suspect, with the appearance of both discs on
the right atrial aspect of the aorta. On detailed examination
with ICE, however, atrial septum could clearly be seen
between the discs, and it appeared that the device itself was
compressed between the aorta and superior caval vein.
Transesophageal echocardiographic images were similar,
though the lower resolution did not demonstrate septum
between the device disks. Although no significant color flow
leak could be detected, the TEE operator considered the
device to be malpositioned. The device was therefore
redeployed using ICE, but a very similar appearance was
apparent. After further assessment, septal capture was con-
sidered satisfactory on the basis of ICE images, with septum
seen coursing between the discs and the absence of a
significant residual leak, and the device was released. Sub-
sequent assessment with ICE and TEE confirmed satisfac-
tory device position and occlusion of the defect with no
residual leaks or superior caval vein obstruction.
Device redeployments and adverse events. A total of
eight adverse events were logged in seven patients (Fig. 3).
These were classified as procedural events that required
remedial action, and if undetected would alter the integrity
of the device closure. Intracardiac echocardiography imag-
ing detected device malpositions in four patients before
release of the device from its delivery system and guided
appropriate redeployment in all cases. In addition, in one
patient ICE imaging identified a large additional ASD that
had not been detected by TEE. In one patient with a grossly
aneurysmal intraatrial septum and multiple fenestrations,
ICE imaging did not adequately demonstrate the anatomy
of a second small ASD. In this case TEE was used to guide
deployment of a 6-mm Amplatzer septal occluder. No
malpositions or adverse events were noted by TEE that
were not initially detected using ICE, and all devices
implanted remained in a satisfactory position at six weeks
follow-up by transthoracic echocardiography.
Assessment after device release. Following release, the
device position was confirmed as being satisfactory in all
cases by ICE and TEE (100% agreement). A residual leak
was detected in eight patients by TEE (6 trivial; 2 moder-
ate), and of these, four (50%) were also detected by ICE,
including both moderate leaks. In the other cases the leaks
seen on TEE appeared to be related to small additional
defects. In one patient with a windsock atrial septum, with
at least two defects, a second defect was not seen on ICE but
Figure 3. Adverse procedural events detected by intracardiac echocardiography. (A and B) Malpositioned Cardioseal and Amplatzer devices with both discs
on right atrial (RA) side of aorta (Ao). (C) Color flow demonstrates a residual leak in this patient, with two devices already deployed. Intracardiac
echocardiography demonstrated this to be a small additional fenestration. (D) This second large inferior defect was not identified by transesophageal
echocardiography. Note the sizing balloon inflated within a more superior defect and the coronary sinus (CS) and mitral valve (MV).
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was noted on TEE and transthoracic echocardiography at
follow-up.
Follow-up. At six-week follow-up all devices were re-
ported to be in a satisfactory position. Of the eight patients
in whom a leak was noted immediately post deployment,
this was still apparent in six patients.
Complications. The ICE transducer passed easily to the
RA in all patients, generally without the use of fluoroscopy,
and was not associated with additional discomfort. One
patient developed atrial tachycardia on introduction of the
transducer into the RA and again during manipulation of
either transducer or catheter within the heart. This sponta-
neously reverted to sinus rhythm during the case and did not
impact on the quality of ICE imaging. There were no
significant vascular complications, though one patient, in
whom ICE was used as the only imaging modality, devel-
oped an area of parasthesia over the lateral aspect of the
right thigh two days after discharge consistent with a palsy
of the lateral cutaneous nerve of the thigh. Vascular ultra-
sound did not demonstrate a hematoma with normal pa-
tency of the both the femoral artery and vein. Despite this,
at the time of the six-week follow-up visit the symptoms
had not fully resolved. One patient developed atrial fibril-
lation two weeks after successful implantation of a 28-mm
Amplatzer septal occluder. This patient subsequently re-
verted to sinus rhythm and has remained stable since.
DISCUSSION
In this study we have assessed the accuracy and feasibility of
ICE imaging in guiding device closure of secundum ASDs.
High-quality images of the intraatrial septum and surround-
ing structures were achieved in all patients and ICE was
used to successfully guide the closure of a wide range of
defects. A close agreement between ICE and TEE in their
assessment of the adequacy of device position was found and
ICE detected all the procedural events that might have
impacted on the success of the implantation and guided
appropriate remedial action. These data indicate that ICE
may be used to guide routine closure of the majority of
ASDs in adults without the need for TEE and general
anesthesia.
The utility of ICE in guiding interventional procedures
will depend on feasibility with which images of diagnostic
quality are achieved in the majority of patients and the
sensitivity and specificity with which adverse procedural
events are detected. During device closure of ASDs, the
most significant imaging issue is malposition of the device,
whereby the rim of the atrial septum has not been ade-
quately captured and, if released, can result in device
embolization. In this instance surgical extraction may be
necessary. Inaccurate sizing or poor device positioning
might also result in residual leaks. An additional important
role of periprocedural echocardiography is to demonstrate
the presence of additional defects or fenestrations and to
ensure that the device is free of the mitral and tricuspid
valves and does not obstruct the pulmonary or systemic
veins. In a small number of patients, Hijazi et al. (6) recently
reported the use of ICE in the closure of ASDs and patent
foramen ovales. The incidence of malpositions was not
noted and therefore it is not possible to determine the
accuracy of ICE in detecting such potentially adverse
procedural events. In our larger study, which included
unselected patients with large defects, multiple defects, and
aneurysmal septa, high-quality ICE images of relevant
anatomy were achieved in all patients, and ICE-guided
device closure of ASDs proved feasible in all but one
patient. There was a close agreement between ICE and
TEE in the assessment of the device position at all stages of
the procedure. Intracardiac echocardiography detected all
the procedural events with potentially adverse consequences,
including four malpositions, and guided appropriate reme-
dial action. Furthermore, in two cases the ICE images
proved superior to those of TEE in detecting the presence
of an additional ASD and in confirming the satisfactory
position of a device that appeared malpositioned on TEE.
The ICE transducer used in this study was introduced on
the same side as the sheaths used for deploying the ASD
occluding device, with no vascular complications in this
adult population. Its high resolution and steerable tip
facilitated the detailed assessment of the whole atrial sep-
tum, providing particularly good images of the sinus venosus
septum and origin of the pulmonary veins. These areas are
often difficult to image adequately with TEE because of its
limited near field characteristics. Intracardiac echocardiog-
raphy provided unobstructed views of the device, once
deployed, allowed visualization of atrial septal tissue be-
tween the disks before its release, confirming the satisfactory
capture of the device.
Limitations of ICE. We did not find any limitation in the
use of ICE with large defects or with multiple defects.
Indeed, ICE proved superior to TEE in detecting two
additional ASDs located near the inferior vena cava–RA
junction. Although ICE was used to successfully guide the
closure of seven ASDs in patients with aneurysmal atrial
septa, prolapse of the septum into the RA potentially limits
a complete imaging examination. This was reflected in two
patients with grossly aneurysmal septa in whom second
defects, although detected by the preprocedure TEE, were
not adequately imaged by ICE. In these patients the use of
TEE may continue to be necessary. Further studies will be
needed to ensure the accuracy and safety of ICE in patients
with multiple defects or aneurysmal septa.
Study limitations. Although it was not the primary aim of
this study, we found ICE proved accurate at delineating the
anatomy of the atrial septum, the position and size of the
defects, the adequacy of the rims, and the drainage of
pulmonary veins. However, all of our patients had previ-
ously undergone TEE assessment of the suitability of their
ASD for device closure, and the operators were not blind to
the results of this study, which might have influenced their
assessment. Furthermore, TEE itself has a number of
291JACC Vol. 41, No. 2, 2003 Mullen et al.
January 15, 2003:285–92 Intracardiac Echo-Guided Closure of ASD
limitations, and further studies will be needed to assess the
accuracy of ICE in assessing atrial septal anatomy compared
to three-dimensional echocardiography or cardiac magnetic
resonance imaging.
Summary. Intracardiac echocardiography is a safe tech-
nique that provides intracardiac ultrasound images of com-
parable quality to those derived from TEE. It facilitates the
full assessment of cardiac anatomy and physiology relevant
to device closure of ASDs in the majority of patients. We
have demonstrated comparable accuracy and reliability of
ICE and TEE in guiding device closure of ASDs. Intra-
cardiac echocardiography detected all adverse events that
were likely to affect the successful outcome of the procedure,
and will facilitate the closure of ASD without the need for
general anesthesia. This will increase the safety and tolera-
bility of this procedure.
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